ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC46894 |
|
— |
Atropine-d5
|
0 | C17H18D5NO3 | |
GC46893-10mg |
|
479-20-9 |
Atranorin
|
0 | C19H18O8 | |
GC46893-5mg |
|
479-20-9 |
Atranorin
|
0 | C19H18O8 | |
GC46893-1mg |
|
479-20-9 |
Atranorin
|
0 | C19H18O8 | |
GC46893-500μg |
|
479-20-9 |
Atranorin
|
0 | C19H18O8 | |
GC46892-10mg |
|
1037543-26-2 |
ATRA-BA Hybrid
|
0 | C31H40O4 | |
GC46892-5mg |
|
1037543-26-2 |
ATRA-BA Hybrid
|
0 | C31H40O4 | |
GC46892-1mg |
|
1037543-26-2 |
ATRA-BA Hybrid
|
0 | C31H40O4 | |
GC46891-5mg |
|
— |
ATPA (hydrate)
|
0 | C10H16N2O4.XH2O | |
GC46891-1mg |
|
— |
ATPA (hydrate)
|
0 | C10H16N2O4.XH2O | |
GC46890-1mg |
|
222412-82-0 |
Atorvastatin-d5 (calcium salt)
|
0 | C29H30D5FN2O5.1/2Ca | |
GC46890-500μg |
|
222412-82-0 |
Atorvastatin-d5 (calcium salt)
|
0 | C29H30D5FN2O5.1/2Ca | |
GC46889-50mg |
|
357164-38-6 |
Atorvastatin (calcium salt hydrate)
|
0 | C33H34FN2O5.1/2Ca [XH2O] | |
GC46889-25mg |
|
357164-38-6 |
Atorvastatin (calcium salt hydrate)
|
0 | C33H34FN2O5.1/2Ca [XH2O] | |
GC46889-10mg |
|
357164-38-6 |
Atorvastatin (calcium salt hydrate)
|
0 | C33H34FN2O5.1/2Ca [XH2O] | |
GC46889-5mg |
|
357164-38-6 |
Atorvastatin (calcium salt hydrate)
|
0 | C33H34FN2O5.1/2Ca [XH2O] | |
GC46888-5mg |
|
— |
ATI-2341 (trifluoroacetate salt)
|
0 | C104H178N26O25S2.XCF3COOH | |
GC46888-1mg |
|
— |
ATI-2341 (trifluoroacetate salt)
|
0 | C104H178N26O25S2.XCF3COOH | |
GC46888-500μg |
|
— |
ATI-2341 (trifluoroacetate salt)
|
0 | C104H178N26O25S2.XCF3COOH | |
GC46887-1mg |
|
1092540-50-5 |
Atazanavir-d6
|
0 | C38H46D6N6O7 | |